US EditionPublished • loading... • Updated
Voyageur Pharmaceuticals Achieves Pharmaceutical-Grade Purity Milestone, Advances to Human Clinical Trials
Summary by citybuzz.co
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
thenewswire.comReposted by 
NewMediaWire
NewMediaWireVoyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant; Announces Stock Option and DSU grants, and Proposed Issuance of Securities for Debt
Open the article to view the coverage from thenewswire.com
Voyageur Pharmaceuticals Achieves Pharmaceutical-Grade Purity Milestone, Advances to Human Clinical Trials
Voyageur Pharmaceuticals Ltd. has confirmed independent laboratory test results showing its natural barium sulfate active pharmaceutical ingredient achieves purity exceeding pharmaceutical-grade requirements. The material, sourced from the company’s Frances Creek barite property in British Columbia, demonstrated 98.8% average purity with results ranging from 98.1% to 99.4%, surpassing the United States Pharmacopeia requirement of 97.5%. Testing …
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
